U. Tunn

1.8k total citations
59 papers, 1.4k citations indexed

About

U. Tunn is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Urology. According to data from OpenAlex, U. Tunn has authored 59 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 20 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Urology. Recurrent topics in U. Tunn's work include Prostate Cancer Diagnosis and Treatment (34 papers), Prostate Cancer Treatment and Research (30 papers) and Hormonal and reproductive studies (19 papers). U. Tunn is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (34 papers), Prostate Cancer Treatment and Research (30 papers) and Hormonal and reproductive studies (19 papers). U. Tunn collaborates with scholars based in Germany, Netherlands and United States. U. Tunn's co-authors include Nikolaos Zamboglou, Ralf Kurek, Dimos Baltas, F. Neumann, Thomas J. Martin, Th. Senge, Fritz H. Schröder, Nikolaos Tselis, B. Schenck and Natasa Milickovic and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

U. Tunn

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Tunn Germany 24 881 386 247 236 204 59 1.4k
Sven Wenske United States 21 684 0.8× 34 0.1× 68 0.3× 283 1.2× 228 1.1× 41 1.2k
W.B. Peeling United Kingdom 24 1.2k 1.4× 480 1.2× 14 0.1× 285 1.2× 399 2.0× 64 1.8k
Zew Wajsman United States 19 635 0.7× 126 0.3× 10 0.0× 445 1.9× 62 0.3× 55 1.3k
Michael Froehner Germany 18 520 0.6× 65 0.2× 8 0.0× 348 1.5× 86 0.4× 66 1.0k
F.H. Schr�der Netherlands 16 673 0.8× 46 0.1× 7 0.0× 183 0.8× 118 0.6× 19 858
Robert O. Petersen United States 17 476 0.5× 18 0.0× 15 0.1× 208 0.9× 62 0.3× 38 978
A. W. McKENZIE United Kingdom 13 392 0.4× 55 0.1× 101 0.4× 87 0.4× 4 0.0× 26 1.4k
Yosuke Morizawa Japan 16 382 0.4× 22 0.1× 15 0.1× 571 2.4× 192 0.9× 143 1.3k
Marcos Brasilino de Carvalho Brazil 22 269 0.3× 108 0.3× 14 0.1× 438 1.9× 9 0.0× 84 1.6k
Alan Paul United Kingdom 17 265 0.3× 15 0.0× 17 0.1× 267 1.1× 67 0.3× 29 857

Countries citing papers authored by U. Tunn

Since Specialization
Citations

This map shows the geographic impact of U. Tunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Tunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Tunn more than expected).

Fields of papers citing papers by U. Tunn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Tunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Tunn. The network helps show where U. Tunn may publish in the future.

Co-authorship network of co-authors of U. Tunn

This figure shows the co-authorship network connecting the top 25 collaborators of U. Tunn. A scholar is included among the top collaborators of U. Tunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Tunn. U. Tunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tunn, U., et al.. (2013). Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation. Clinical Interventions in Aging. 8. 457–457. 9 indexed citations
2.
Tselis, Nikolaos, U. Tunn, Georgios Chatzikonstantinou, et al.. (2013). High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients. Radiation Oncology. 8(1). 115–115. 28 indexed citations
3.
Bacher, Peter, et al.. (2012). Safety and tolerability of intermittent androgen deprivation therapy: A literature review. International Journal of Urology. 19(7). 614–625. 18 indexed citations
4.
Tunn, U., et al.. (2012). Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy. Prostate Cancer and Prostatic Diseases. 15(3). 296–302. 30 indexed citations
5.
6.
Berges, R., K. Dreikorn, K. Höfner, et al.. (2009). Therapie des benignen Prostatasyndroms (BPS). Der Urologe. 48(12). 1503–1516. 13 indexed citations
7.
Tunn, U., et al.. (2008). Safety and clinical efficacy of a new 6-month depot formulation of leuprorelin acetate in patients with prostate cancer in Europe. Prostate Cancer and Prostatic Diseases. 12(1). 83–87. 23 indexed citations
8.
Boccon-Gibod, L, Peter Hammerer, Stephan Madersbacher, et al.. (2007). The role of intermittent androgen deprivation in prostate cancer. British Journal of Urology. 100(4). 738–743. 50 indexed citations
9.
Martin, Thomas J., Dimos Baltas, Ralf Kurek, et al.. (2004). 3-D Conformal HDR Brachytherapy as Monotherapy for Localized Prostate Cancer. Strahlentherapie und Onkologie. 180(4). 225–232. 85 indexed citations
10.
Martin, Thomas J., Sandra Röddiger, Ralf Kurek, et al.. (2004). 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. Radiotherapy and Oncology. 71(1). 35–41. 41 indexed citations
11.
Röddiger, Sandra, et al.. (2003). Human kallikrein 2 (hK2) mRNA in peripheral blood of patients with thyroid cancer. Journal of Cancer Research and Clinical Oncology. 129(1). 29–34. 8 indexed citations
12.
Kurek, Ralf, Heiner Renneberg, Lutz Konrad, et al.. (2003). Quantitative PSA RT‐PCR for preoperative staging of prostate cancer. The Prostate. 56(4). 263–269. 13 indexed citations
13.
Baer, Patrick C., et al.. (1999). Transdifferentiation of Distal but Not Proximal Tubular Epithelial Cells from Human Kidney in Culture. Nephron Experimental Nephrology. 7(4). 306–313. 25 indexed citations
14.
Martin, Thomas J., Christos Kolotas, Thomas Dannenberg, et al.. (1999). New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation. Radiotherapy and Oncology. 52(3). 257–260. 20 indexed citations
15.
16.
17.
Gingell, J C, H Knönagel, K. H. Kurth, & U. Tunn. (1995). Placebo Controlled Double-blind Study to Test the Efficacy of the Aromatase Inhibitor Atamestane in Patients with Benign Prostatic Hyperplasia not Requiring Operation. The Journal of Urology. 154(2 Pt 1). 399–401. 15 indexed citations
18.
Habenicht, U.‐F., U. Tunn, Th. Senge, et al.. (1993). Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 44(4-6). 557–563. 24 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Wenske Breakdown of academic impact, for papers by W.B. Peeling Breakdown of academic impact, for papers by Zew Wajsman Breakdown of academic impact, for papers by Michael Froehner Breakdown of academic impact, for papers by F.H. Schr�der Breakdown of academic impact, for papers by Robert O. Petersen Breakdown of academic impact, for papers by A. W. McKENZIE Breakdown of academic impact, for papers by Yosuke Morizawa Breakdown of academic impact, for papers by Marcos Brasilino de Carvalho Breakdown of academic impact, for papers by Alan Paul
Rankless by CCL
2026